Source: GWASDB
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
toll like receptor 1 | 0.496 | 0.808 | 5.9E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 27 subfamily A member 1 | 0.538 | 0.731 | 5.3E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2016 | ||||||||
|
family with sequence similarity 13 member A | 0.653 | 0.462 | 1.9E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 1 | 0.541 | 0.769 | 2.5E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
period circadian regulator 3 | 0.559 | 0.731 | 1.4E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
calcineurin binding protein 1 | 0.536 | 0.846 | 3.3E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2010 | 2019 | ||||||||
|
methionine sulfoxide reductase A | 0.608 | 0.615 | 1.5E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
tetratricopeptide repeat domain 39B | 0.890 | 0.154 | 2.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
farnesyl-diphosphate farnesyltransferase 1 | 0.621 | 0.615 | 4.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
MAP kinase activating death domain | 0.644 | 0.538 | 1.5E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2019 | ||||||||
|
adhesion G protein-coupled receptor D1 | 0.861 | 0.077 | 2.5E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
villin 1 | 0.691 | 0.423 | 2.6E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
phospholipase C delta 4 | 0.861 | 0.154 | 1.3E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 12 | 29 | 2008 | 2019 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
adenosine monophosphate deaminase 3 | 0.743 | 0.385 | 1.1E-12 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | ||||||||
|
diacylglycerol lipase beta | 0.931 | 0.154 | 2.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2019 |